![The glycotope-specific RAV12 monoclonal antibody induces oncosis in vitro and has antitumor activity against gastrointestinal adenocarcinoma tumor xenografts in vivo]()
The glycotope-specific RAV12 monoclonal antibody induces oncosis in vitro and has antitumor activity against gastrointestinal adenocarcinoma tumor xenografts in vivoLoo, D.; Pryer, N.; Young, P.; Liang, T.; Coberly, S.; King, K. L.; Kang, K.; Roberts, P.; Tsao, M.; Xu, X.; Potts, B.; Mather, J. P. · Molecular Cancer Therapeutics · 2007